1,796 material Form 8-K filings that 1,448 companies we cover made with the SEC in May 2026, each read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). All of them were written later, when past filings were added: a selection, not every 8-K of the month (see the note below).
FVCBankcorp furnished an investor presentation under Regulation FD, covering financial data for the quarter ended March 31, 2026, for use in meetings with investors and analysts. The filing is a presentation rather than an earnings release, and it reports no new guidance or transactions, though it sets out the bank's margin, liquidity and funding figures.
Net interest margin was 3.26% and the efficiency ratio was 54.0% for the first quarter of 2026, per the presentation.
Total liquidity sources were $1.26 billion at March 31, 2026, against $936 million of uninsured deposits (134.3% coverage).
Cost of deposits was 2.50% at March 31, 2026, and nonperforming assets were $12.2 million.
In January and February 2026, the company redeemed a $19 million 6% subordinated debt and issued $25 million of 6.75% unsecured debt.
Helix Energy Solutions Group, through subsidiary Helix Alliance Decom, sold all equity interests in its Gulf of America Shallow Water Abandonment business, called Alliance, to C-Dive, L.L.C. for $107.5 million in cash, subject to customary post-closing adjustments. The sale was signed and closed on May 1, 2026, and the filing says it supports Helix's focus on deepwater operations while it pursues a combination with Hornbeck Offshore Services. The filing does not report the business's revenue, profit, or the effect on Helix's financial results.
Sale price: $107.5 million cash at closing, subject to customary post-closing adjustments
Equity Purchase Agreement and closing both dated May 1, 2026; buyer is C-Dive, L.L.C., part of the Chouest Group
Alliance companies released as guarantors under the December 1, 2023 indenture with The Bank of New York Mellon Trust Company, N.A.
Helix separately announced a definitive agreement to combine with Hornbeck Offshore Services
Occidental CEO Vicki Hollub will retire as President and CEO effective June 1, 2026, and will remain on the Board. The Board named Senior Vice President and Chief Operating Officer Richard Jackson, 50, as her successor, effective the same date, with a base salary of $1,400,000 and a $6,000,000 restricted stock unit grant. At the May 1, 2026 annual meeting, shareholders also elected all ten Board nominees and approved the advisory pay vote with 94.34% support.
Vicki Hollub retires as President and CEO effective June 1, 2026, and will continue as a director.
Richard Jackson, 50, joined Occidental in 2003 and has served as Senior Vice President and COO since October 2025.
Jackson's base salary will rise to $1,400,000, his target annual cash incentive will be 150% of base salary, and he will receive $6,000,000 in restricted stock units vesting over three years.
Shareholders approved the advisory vote on named executive officer compensation with 94.34% For and ratified KPMG as auditor with 97.70% For.
Johnson Controls said Vice President and President of Global Products & Solutions Lei Schlitz will leave the company as part of a planned transition tied to changes in its operating model. She is expected to stay through October 1, 2026, and her departure entitles her to severance under the company's officer severance policy.
Lei Schlitz, Vice President and President, Global Products & Solutions, will depart under a planned transition
Determination made May 1, 2026; Schlitz expected to remain through October 1, 2026
Severance benefits apply under the Severance and Change in Control Policy for Officers, filed as Exhibit 10.6 to the fiscal 2025 Form 10-K
General Mills said on May 4, 2026 that director Steve Odland, who has served more than twenty years, will not stand for reelection at the company's September 2026 annual meeting of shareholders. He will remain on the board for the rest of his current term.
Steve Odland informed the company on May 4, 2026 that he will not seek reelection to the Board of Directors.
The decision takes effect at the 2026 Annual Meeting of Shareholders in September.
Odland will continue to serve as a director through the remainder of his current term.
Pasithea Therapeutics Corp. appointed Kartik Krishnan, M.D., Ph.D. as Chief Medical Officer, effective May 1, 2026, to oversee clinical development and medical strategy for its lead drug candidate PAS-004 in neurofibromatosis type 1. The Board also approved stock option awards on May 1, 2026, at an exercise price of $0.841 per share, including 1,129,323 options for Dr. Krishnan.
Dr. Krishnan, age 55, previously served as Chief Executive Officer at OncoNano Medicines and as Chief Medical Officer at Arcus Biosciences.
Initial annual base salary of $500,000, with a discretionary bonus of up to 40% of base salary; employment is at-will and includes severance in specified circumstances.
Options for 1,129,323 shares at $0.841 per share vest 33% on the one-year anniversary of the May 1, 2026 grant date, with the remainder vesting quarterly over the following two years.
Four non-employee directors each received options for 152,783 shares at $0.841 per share, vesting in full on the one-year anniversary of the grant date.
CBRE Services, a wholly owned subsidiary of CBRE Group, completed a $750 million offering of 5.250% senior notes maturing June 1, 2036, guaranteed by the parent. The company said it intends to use the net proceeds to repay commercial paper borrowings, which shifts short-term debt into longer-term fixed-rate debt.
Principal amount: $750 million; issue date May 4, 2026; interest of 5.250% paid semi-annually
Notes mature June 1, 2036; first interest payment due December 1, 2026
Proceeds to repay borrowings under the company's commercial paper program
Indenture includes limits on liens, sale/leaseback transactions and mergers, and events of default including nonpayment
WEX entered a cooperation agreement with Impactive Capital Master Fund LP on May 3, 2026. The Board will expand to 11 directors, nominate Kurt Adams, Ellen Alemany and Lauren Taylor Wolfe, and separate the Chair and CEO roles after the annual meeting, while the meeting is postponed from May 5 to May 14, 2026. The changes alter the board's composition and governance, and shareholders who already voted on Impactive's white proxy card must submit new voting instructions.
Cooperation Agreement with Impactive Capital Master Fund LP dated May 3, 2026; Impactive will withdraw its nomination notice.
Board to be set at 11 directors as of the 2026 annual meeting, including new nominees Kurt Adams, Ellen Alemany and Lauren Taylor Wolfe.
Annual meeting postponed from May 5, 2026 to May 14, 2026; the record date is unchanged.
Chair and CEO roles to be separated after the annual meeting; Melissa Smith will continue as CEO and President.
Edwards Lifesciences said on May 4, 2026 that Theodora Mistras, currently CFO of Viatris, will become corporate vice president and chief financial officer effective May 29, 2026, succeeding Scott Ullem, who has held the role since 2014. The Offer Letter sets a $925,000 base salary, a $2,013,000 sign-on bonus, and an $8,000,000 initial RSU grant, with a $4,500,000 target fiscal 2026 annual equity award, which shareholders can use to gauge the cost of the leadership change.
Mistras, age 44, has been CFO of Viatris since March 1, 2024; previously a managing director at Citigroup and Goldman Sachs healthcare investment banking.
Offer Letter dated May 2, 2026: $925,000 base salary and target annual bonus of not less than 100% of base salary, plus a $2,013,000 sign-on bonus.
Initial RSU award with a grant date value of $8,000,000, vesting 43.75%, 50% and 6.25% on the first, second and third anniversaries of her start date.
Scott Ullem announced his planned transition in October; the press release says he will continue as a strategic advisor in the months ahead.
Viatris said Chief Financial Officer Doretta Mistras will leave the company to pursue another professional opportunity, effective May 8, 2026, and will stay on until May 22, 2026 for transition. Chief Accounting Officer and Corporate Controller Paul Campbell will serve as interim CFO starting May 8 while the board searches for a permanent CFO, and the company will report first-quarter 2026 results on May 7.
Mistras ceases to serve as CFO effective May 8, 2026, and remains employed until May 22, 2026 for transition purposes.
Paul Campbell, age 59, is appointed interim CFO effective May 8, 2026, and continues as Chief Accounting Officer and Corporate Controller.
Mistras will not receive severance or equity vesting, but is eligible for a pro rata 2026 bonus based on actual company performance, not to exceed target.
The company will release first-quarter 2026 financial results on May 7, 2026, with a conference call at 8:30 a.m. ET.
On May 4, 2026, Meta Platforms completed the sale of $25 billion in senior notes in six tranches maturing from 2031 to 2066. The filing shows the company is adding a large amount of long-term debt, which shareholders may watch for its effect on the company's borrowing costs and balance sheet.
Six tranches total $25 billion: $3 billion due 2031, $2 billion due 2033, $6 billion due 2036, $4 billion due 2046, $6 billion due 2056, and $4 billion due 2066.
Coupons range from 4.550% on the 2031 notes to 6.450% on the 2066 notes.
Citigroup Global Markets Inc. and Morgan Stanley & Co. LLC served as representatives of the underwriters under an agreement dated April 30, 2026.
The notes were issued under a fifth supplemental indenture to a base indenture with U.S. Bank Trust Company, National Association, as trustee.
SAB Biotherapeutics entered a Master Manufacturing Services Agreement with Emergent BioSolutions Canada, effective April 28, 2026, under which Emergent will make SAB-142 clinical and commercial supply at its Canadian facility. The agreement sets a minimum aggregate spend of $36 million following any FDA approval of the product, and gives Emergent exclusive manufacturing rights during the term.
Agreement effective April 28, 2026, running five years from FDA approval of SAB-142
Minimum aggregate spend of $36 million following any FDA approval
Emergent has sole and exclusive right to manufacture the product; batch pricing to be set in a later amendment
Early termination by Emergent for insolvency, non-payment or material breach triggers payment of minimum annual spend for remaining years, less saved costs
Pool Corporation said Peter D. Arvan will step down as President, CEO and director effective May 4, 2026, and the Board appointed John B. Watwood as his successor. Board Chair John E. Stokely was named Executive Chair, and the company reaffirmed its full-year 2026 guidance range, but it postponed its May 12, 2026 Investor Day.
Watwood, age 47, joined Pool Corp as executive vice president in January 2026; his employment agreement sets a $800,000 annual salary and a 125% target bonus
Watwood's initial equity grant is valued at approximately $1,750,000, split equally between restricted and performance-based shares
Stokely receives a $50,000 monthly fee as Executive Chair; David G. Whalen serves as interim lead independent director at $5,000 per month
The company continues to expect full-year 2026 results within the range in its April 23, 2026 first quarter release; the May 12, 2026 Investor Day is postponed
CooperCompanies approved expanding its board from nine to ten directors and appointed Paul Keel, currently President and CEO of Envista Holdings, to the new seat effective July 1, 2026. Keel will also join the Audit Committee on the same date, and the company says he is independent under Nasdaq standards.
Board size increases from nine to ten directors, effective July 1, 2026
Paul Keel has been CEO of Envista Holdings since 2024 and previously was CEO of Smiths Group from 2021 to 2024
Keel joins the Audit Committee effective July 1, 2026
Keel will receive director compensation consistent with other non-employee directors, per the February 24, 2026 proxy statement
West Enclave Merger Corp., a Cayman Islands blank check company listed on the NYSE, closed its initial public offering of 10,000,000 units on May 1, 2026, at $10.00 per unit for gross proceeds of $100,000,000. A simultaneous private placement of 425,000 units added $4,250,000, and $101,000,000 was placed in a trust account that holds the funds until a business combination is completed or shareholders redeem their shares.
IPO closed May 1, 2026: 10,000,000 units at $10.00 each, $100,000,000 gross proceeds; units trade on NYSE as "WENC U".
Private placement of 425,000 units to the sponsor and EarlyBirdCapital for $4,250,000, closed May 1, 2026.
$101,000,000 placed in trust; if no business combination within 21 months of the offering closing, public shares are redeemed unless shareholders approve an extension.
Board expanded to five members on April 29, 2026, with Jean-Michel Enriquez Dahlhaus and Hector Madero Rivero added; indemnity agreements signed with all directors and officers.
Block, Inc. named Andrea Acosta, formerly Chief Accounting Officer of Pinterest, as its principal accounting officer, effective May 26, 2026, succeeding interim principal accounting officer Amrita Ahuja, who remains Chief Financial Officer and Chief Operating Officer. The role is a senior finance position, and the filing describes pay of a $550,000 base salary and an $8.0 million restricted stock unit grant, which is routine for an executive appointment.
Andrea Acosta appointed Chief Accounting Officer by the Board on April 30, 2026, effective May 26, 2026
Acosta previously was Chief Accounting Officer of Pinterest, Inc. from February 2022
Compensation includes a $550,000 annual base salary, a $250,000 sign-on cash bonus, and an $8.0 million restricted stock unit award vesting over four years
On May 1, 2026, Hubbell agreed to acquire NSI Industries, a maker of electrical fittings, connectors and wire management products, for $3.0 billion in cash, subject to customary adjustments. Hubbell plans to fund the deal with cash on hand and debt, and the closing depends on regulatory clearance and other conditions. For shareholders, the deal is large relative to Hubbell's $5.8 billion of 2025 revenue, and the company expects it to be accretive to adjusted EPS in 2026.
Purchase price is $3.0 billion in cash, which the press release says represents about 15.5 times NSI's anticipated 2026 EBITDA.
NSI anticipates 2026 revenue of approximately $570 million; Hubbell expects the acquisition to be accretive to adjusted EPS in 2026.
Commitment letter dated May 1, 2026 with JPMorgan Chase, Bank of America and HSBC provides up to $2.8 billion of senior unsecured bridge loans.
Hubbell would pay a $150 million termination fee if the deal ends for failure to obtain antitrust approvals; the closing cannot occur before May 31, 2026 without Hubbell's consent.
General Catalyst Global Resilience Merger Corp. closed its initial public offering on May 1, 2026, selling 40,250,000 GRAIL securities at $10.00 each, including the full exercise of the underwriters' over-allotment option, for gross proceeds of $402.5 million. The company is a blank check company with no business combination announced in the filing, and its proceeds are to be held in a trust account until it completes an initial business combination.
40,250,000 GRAIL securities sold at $10.00 each on May 1, 2026, for gross proceeds of $402.5 million, including 5,250,000 over-allotment securities
Sponsor GCGR Sponsor LLC bought 905,000 private placement GRAIL securities for $9.05 million
GRAIL securities began trading on Nasdaq as GCGRU on April 30, 2026; shares and warrants are expected to trade as GCGR and GCGRW once separated
Company must complete an initial business combination within 24 months of April 29, 2026, or 27 months if a letter of intent or agreement was signed within that period
At its April 28, 2026 annual meeting, Brink's shareholders approved an amended and restated 2024 Equity Incentive Plan that adds 3,900,000 shares of common stock for issuance under the plan. Shareholders also elected nine directors, approved an advisory pay vote and ratified KPMG LLP as auditor, and rejected a shareholder proposal on employee retention rates by demographic category.
Amended plan adds 3,900,000 shares of common stock; approved at the April 28, 2026 annual meeting
Nine nominees elected to terms expiring in 2027
Advisory vote on named executive compensation approved: 35,902,479 for, 419,407 against
Shareholder proposal on employee retention rates defeated: 2,619,075 for, 33,439,945 against
At its April 29, 2026 annual meeting, Ingevity stockholders elected nine directors to one-year terms, approved a non-binding advisory vote on executive pay, ratified PricewaterhouseCoopers LLP as auditor for fiscal 2026, and approved an amendment adding 580,000 shares to the 2025 Omnibus Incentive Plan. The filing reports vote tallies only; it does not describe any change in company results or strategy.
Stockholders approved the plan amendment, with 31,038,374 votes for and 990,650 against.
The say-on-pay proposal passed with 28,593,615 votes for and 3,435,921 against.
Shares represented at the meeting were 33,498,332, or 95.10% of the 35,222,538 outstanding on the record date.
PricewaterhouseCoopers LLP was ratified with 33,358,881 votes for and 118,571 against.
Madison Square Garden Sports Corp. appointed Paul DiCicco as Executive Vice President, Chief Financial Officer and Treasurer, effective May 11, 2026, or a later agreed date. Victoria Mink, the current CFO, will leave that role on the same date and remain with the company as Executive Vice President, Finance to assist with the transition.
Paul DiCicco, 51, has been CFO of Stephen Gould Corporation since 2023 and previously served as SVP, Corporate Controller at Harris Blitzer Sports and Entertainment.
Employment agreement dated April 28, 2026 sets annual base salary of not less than $650,000 and annual target bonus of not less than 100% of base salary, starting with the fiscal year beginning July 1, 2026.
Expected long-term awards with an aggregate target value of not less than $650,000.
If terminated without cause or for good reason before the Scheduled Expiration Date of May 10, 2029, severance is no less than two times the sum of base salary and target bonus, subject to a separation agreement.
Rein Therapeutics closed on May 4, 2026 the sale of 50,000,000 shares of common stock at $1.00 per share under an April 30 underwriting agreement with Konik Capital Partners, with net proceeds expected to be about $46.1 million. The company said the proceeds, with existing cash, are expected to fund operations into 2028 and its Phase 2 LTI-03 trial through completion. The offering adds shares outstanding and the filing also includes warrants to the underwriter and to Bios entities, which dilute existing shareholders.
50,000,000 shares sold at $1.00 per share before underwriting discounts; closed May 4, 2026
Expected net proceeds of about $46.1 million; underwriter has a 45-day option for up to 7,500,000 more shares
Underwriter warrants for up to 3% of shares sold, exercisable at $1.50 per share through April 30, 2031
Bios entities to receive warrants for 3,000,000 shares at $1.00 per share and defer conversion of 12,232 Series X preferred shares
Alcoa and its subsidiaries signed Amendment No. 3 to their revolving credit agreement with JPMorgan Chase Bank, N.A. as administrative agent. The amendment extends the facility's maturity to June 27, 2028 and removes certain credit spread and sustainability rate adjustments, while the total commitment stays at $1.25 billion. The filing describes this as an amendment of existing financing rather than new borrowing, and it does not report any drawn amount.
Revolving facility maturity extended to June 27, 2028
Aggregate commitments remain at $1.25 billion
Credit spread adjustment and sustainability rate adjustments removed
Participating lenders received a fee of 0.05% of their commitments
Adeia CEO Paul E. Davis told the company and board on May 4, 2026, that he intends to step down as CEO and as a director to focus on his health and personal pursuits. He will remain in both roles until a successor is named, with a target for completing the search by the fourth quarter of 2026.
Davis has served as CEO for the past four years and has been with the company nearly 15 years, including predecessor companies.
A board Transition Committee, chaired by Chairman Dan Moloney, will lead the search and consider internal and external candidates, assisted by a nationally recognized search firm.
The filing states the decision is not the result of any disagreement with the company.
Davis stated the company is in a strong financial, strategic and operational position, and the company cited record revenue and earnings in 2025.
G-III Apparel's Compensation Committee awarded performance share units to five named executive officers, led by Chairman and CEO Morris Goldfarb with 115,163 PSUs. The awards vest based on three-year cumulative Adjusted EBIT and average ROIC for fiscal 2027 through fiscal 2029, so the final share count could be higher or lower than the number awarded.
Morris Goldfarb 115,163 PSUs; Sammy Aaron 86,372; Jeffrey Goldfarb 33,589; Dana Perlman 15,994; Neal S. Nackman 7,997
Adjusted EBIT metric covers 75% of each award; ROIC metric, reduced by a hypothetical 28.5% tax rate, covers 25%
Vesting for each metric can range from 50% to 150% of awarded PSUs, with no vesting below the minimum threshold
Performance period is fiscal 2027 through fiscal 2029; settlement on or within 90 days after April 15, 2029, subject to continued service
Intuitive Surgical's board raised the authorized amount under its stock repurchase program to an aggregate $5.0 billion, including amounts remaining under prior authorization. At its April 30, 2026 annual meeting, stockholders elected all ten board nominees, approved the advisory pay vote, ratified PricewaterhouseCoopers LLP, and approved an amended 2010 incentive plan that adds 5,000,000 shares to the reserve.
Repurchase program authorization raised to an aggregate $5.0 billion, including amounts remaining under previous authorization, approved April 30, 2026
Amended 2010 Incentive Award Plan increases reserved shares from 120,350,000 to 125,350,000 and extends the term to January 29, 2036
All ten director nominees elected to serve until the 2027 annual meeting; Proposal No. 2 pay vote approved on an advisory basis
Company says repurchases may be suspended at any time and will be funded through cash, cash equivalents, and investments
Damora Therapeutics said its Chief Financial Officer, Lori Firmani, ceased serving in that role effective May 1, 2026. Brian Burkavage, the company's Senior Vice President, Finance, was appointed principal financial officer and principal accounting officer at the same time. Firmani's separation benefits are conditional on her signing a separation agreement and general release.
Firmani's departure took effect May 1, 2026; the Board decided on April 28, 2026.
Firmani's separation benefits include a $6,000 health savings account contribution and full acceleration of her outstanding equity awards, subject to a release of claims.
Burkavage joined Damora in December 2025 and previously served as Senior Vice President, Finance and Chief Accounting Officer at IO Biotech, Inc. from November 2021 to December 2025.
Cogent Communications stockholders approved the Third Amended and Restated 2017 Incentive Award Plan at the May 1, 2026 annual meeting. The plan adds 1.5 million shares and extends the award deadline to March 19, 2036. On May 4, 2026, the company also granted CEO David Schaeffer a 1,000,000-share restricted stock award that vests only if the stock's volume weighted average price reaches $70, $85 or $100.
Plan vote: 25,506,567 for, 8,664,157 against, 124,722 abstain, and 4,440,718 broker non-votes
CEO award tranches: 200,000 shares at $70.00, 300,000 at $85.00 and 500,000 at $100.00 VWAP targets
Schaeffer must remain CEO through December 31, 2028; unvested shares are forfeited February 28, 2031
All eight director nominees were elected, and Ernst & Young LLP was ratified as auditor with 38,382,379 votes for
American Express issued $1.75 billion aggregate principal amount of 4.444% Fixed-to-Floating Rate Notes due May 3, 2030 on May 4, 2026, under an existing prospectus supplement dated April 27, 2026. The filing is administrative, covering the note issuance and related legal exhibits, and it does not report new financial results or changes to guidance.
Principal amount: $1,750,000,000 of 4.444% Fixed-to-Floating Rate Notes
Issuance date: May 4, 2026; maturity: May 3, 2030
Issued under a senior indenture with The Bank of New York Mellon as trustee, supplemented in 2021 and 2023
Filing includes a legal opinion from Benjamin L. Kuder, Esq. and an inline XBRL cover page
At its April 30, 2026 annual meeting, Globe Life shareholders elected all 12 director nominees to one-year terms, approved the 2026 Incentive Plan and 2025 executive compensation on an advisory basis, and ratified Deloitte & Touche LLP as auditor for 2026. Directors Linda L. Addison and Marilyn A. Alexander retired from the board at the meeting. The votes are routine governance matters and the filing reports no financial results.
Shareholders elected all 12 director nominees to one-year terms at the April 30, 2026 annual meeting.
Say-on-pay: 55,385,745 votes for and 6,887,045 against the 2025 executive compensation.
2026 Incentive Plan: 57,917,710 votes for and 4,271,772 against.
Deloitte & Touche LLP ratified as 2026 independent auditor with 67,622,465 votes for and 3,212,321 against.
On April 30, 2026, Flex entered into a $1.45 billion senior delayed draw term loan credit facility with Citibank, N.A. as administrative agent. Flex said it will use the proceeds for general corporate purposes, including financing its acquisition of Electrical Power Products, Inc. (EP²), which it announced on May 4, 2026 had been completed. The facility adds borrowing capacity and debt covenants that shareholders should weigh against the company's leverage.
Credit facility totals $1.45 billion and matures 364 days after the first funding date of the term loans
Loans bear interest at Term SOFR or Base Rate plus a margin tied to Flex's senior unsecured debt ratings
Covenants require a Debt/EBITDA ratio of no more than 4.00 to 1.00 and an Interest Coverage Ratio of at least 3.00 to 1.00
EP² acquisition completion announced May 4, 2026; obligations are not guaranteed by any subsidiary at this time
At its April 28, 2026 annual meeting, Williams stockholders approved an amendment that raises the shares issuable under the 2007 Incentive Plan from 50,000,000 to 85,000,000 and removes the plan expiration date. All ten director nominees were elected to one-year terms, and the company's auditor, Ernst & Young LLP, was ratified for fiscal 2026. The votes give shareholders a record of how they voted on pay, equity plans and board composition.
Stockholders approved raising the Incentive Plan's issuable shares from 50,000,000 to 85,000,000, effective April 28, 2026.
Stockholders approved raising the Employee Stock Purchase Plan's issuable shares from 5,200,000 to 7,200,000 and extending its term six years.
All ten director nominees were elected to one-year terms; Stephen W. Bergstrom received 930,781,739 votes for and 55,362,318 against.
Ernst & Young LLP was ratified as independent auditor for the year ending December 31, 2026, with 1,034,329,205 votes for.
Trex Company appointed Zachary C. Lauer as Senior Vice President, Chief Operations Officer, effective April 28, 2026, giving him oversight of manufacturing, supply chain, engineering, and R&D. At the same April 28 annual meeting, stockholders elected four directors, approved executive pay on an advisory basis, and ratified Ernst & Young LLP as auditor.
Lauer, age 53, joined Trex in 2016 and most recently served as Senior Vice President, Supply Chain and Manufacturing; base salary is $493,000
Target annual cash incentive is 60% of base salary; long-term equity incentive target is 135% of base salary
Four directors elected to three-year terms ending at the 2029 annual meeting; advisory pay vote drew 44,939,698 for and 34,703,577 against
Ernst & Young LLP ratified as independent auditor with 85,831,316 votes for and 3,694,637 against
On May 2, 2026, Axos Bank completed its acquisition of all United States consumer deposits of Jenius Bank, a digital banking business of SMBC MANUBANK, under a purchase and assumption agreement dated February 12, 2026. The bank acquired about $2.3 billion of deposits and received cash, less a negotiated premium. The filing does not state the premium amount or the effect on Axos's financial results.
Deal closed May 2, 2026, with about $2.3 billion of Jenius Bank deposits acquired
Seller is SMBC MANUBANK, parent of the Jenius Bank digital banking business
Agreement dated February 12, 2026, was filed as Exhibit 99.1 to an earlier 8-K on the same date
Agilent appointed Michael Buckner as its new Chief Legal Officer effective May 4, 2026, and Bret DiMarco resigned from his roles as Senior Vice President, Chief Legal Officer and Secretary. DiMarco will stay on as a Special Advisor through December 1, 2026, under a transition agreement previously disclosed on March 31, 2026. The filing is a leadership change in the legal function and does not include financial results or guidance.
Michael Buckner, previously vice president, deputy general counsel and chief M&A counsel at Danaher Corp., became Chief Legal Officer effective May 4, 2026.
Bret DiMarco resigned as Senior Vice President, Chief Legal Officer and Secretary effective May 4, 2026.
DiMarco will remain employed as a Special Advisor through December 1, 2026.
Buckner previously spent 16 years at General Electric, most recently as vice president and chief counsel for mergers and acquisitions.
At its annual meeting on May 1, 2026, AMN Healthcare shareholders elected nine directors, approved Amendment No. 1 to the AMN Healthcare 2025 Equity Plan, approved executive pay on an advisory basis, and ratified KPMG LLP as auditor for fiscal 2026. A shareholder proposal calling for an independent board chairman was not approved. The filing reports voting results and does not report financial results.
Equity plan amendment approved: 28,909,689 for and 895,750 against.
Independent board chairman proposal not approved: 7,495,013 for and 22,327,804 against.
Advisory vote on named executive officer pay approved: 22,728,186 for and 7,071,111 against.
KPMG LLP ratified as independent registered public accounting firm for the year ending December 31, 2026: 33,170,877 for and 1,064,827 against.
On May 3, 2026, Global Net Lease (NYSE: GNL) signed a merger agreement to acquire Modiv Industrial (NYSE: MDV) in an all-stock transaction with an enterprise value of approximately $535 million. The deal requires approval by Modiv stockholders but no GNL stockholder vote, and it is expected to close in the third quarter of 2026. GNL says the deal would be immediately 4% accretive to AFFO per share and leverage-neutral, and existing GNL stockholders are expected to own about 89% of the combined company.
Each Modiv common share converts into 1.975 GNL common shares; Modiv Series A preferred holders receive $25.00 in cash plus accrued dividends.
GNL expects an immediate 4% accretion to AFFO per share and about $6 million of annual identified synergies.
Expected closing in the third quarter of 2026; the Outside Date is February 3, 2027.
Termination fees are $10 million payable by Modiv in certain cases and $15 million payable by the non-terminating party after a material uncured breach.
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.
Briefs marked “Written later” were written in November 2026 for filings that were by then more than three weeks old, so months before mid-October 2026 hold a selection: every material 8-K of the past year for the 100 largest companies we cover and the last 15 important 8-Ks of every other one. Briefs the number check holds back are not shown or counted. Also: the last 45 days, briefs by company, A–Z and the live SEC filings wire.